CHC LABS INC.
|
SERUM PHOSPHORUS (84100) |
|
|
135 |
Sarcoidosis |
|
170.0-170.9 |
Malignant neoplasm of bone and articular cartilage |
|
198.5 |
Secondary malignant neoplasm of bone and bone marrow |
|
203.00-203.01 |
Multiple myeloma |
|
238.6 |
Neoplasm of uncertain behavior of plasma cells (solitary myeloma) |
|
252.0 |
Hyperparathyroidism |
|
260-263.9 |
Nutritional deficiencies |
|
268.0-268.9 |
Vitamin D deficiency |
|
275.2 |
Disorders of magnesium metabolism (hypomagnesemia) |
|
275.3 |
Disorders of phosphorus metabolism |
|
275.40-275.49 |
Disorders of calcium metabolism |
|
276.0-276.9 |
Disorders of fluid, electrolyte, and acid-base balance |
|
278.4 |
Hypervitaminosis D |
|
278.8 |
Other metabolic disorders due to hyperalimentation (excess phosphate) |
|
287.0-287.9 |
Purpura and other hemorrhagic conditions |
|
293.0-293.1 |
Acute and subacute delirium (confusion) |
|
298.9 |
Unspecified psychosis (mental obtundation) |
|
348.3 |
Encephalopathy, unspecified |
|
403.01 |
Malignant hypertensive renal disease with renal failure |
|
403.11 |
Benign hypertensive renal disease with renal failure |
|
404.02 |
Malignant hypertensive heart and renal disease with renal failure |
|
404.03 |
Malignant hypertensive heart and renal disease with heart failure and renal failure |
|
404.12 |
Benign hypertensive heart and renal disease with renal failure |
|
404.13 |
Benign hypertensive heart and renal disease with heart failure and renal failure |
|
579.0-579.9 |
Intestinal malabsorption |
|
580.0-588.9 |
Nephritis, nephrotic syndrome, and nephrosis |
|
728.89 |
Other disorders of muscle, ligament, and fascia (rhabdomyolysis) |
|
728.9 |
Unspecified disorder of muscle, ligament, and fascia (muscle weakness and soreness) |
|
729.1 |
Myalgia and myositis, unspecified |
|
731.0 733.90 |
Osteitis deformans without mention of bone tumor Disorder of bone and cartilage, unspecified (bone pain) |
|
753.9 |
Unspecified anomaly of urinary system (congenital renal tubular defects) |
|
780.39 |
Other convulsions |
|
782.0 |
Disturbance of skin sensation (paresthesias) |
|
783.0 |
Anorexia |
|
787.02 |
Nausea alone |
|
790.6 |
Other abnormal blood chemistry |
|
790.7 |
Bacteremia |
|
793.0 |
Nonspecific abnormal findings on radiological examination of skull and head (skeletal lesions) |
|
793.7 |
Nonspecific abnormal findings on radiological examination of musculoskeletal system (skeletal lesions) |
|
799.2 |
Nervousness (apprehension) |
|
965.1 |
Poisoning by salicylates |
|
990 |
Effects of radiation, unspecified (phosphate release from tissue destruction or ischemia) |
|
995.84 |
Adult neglect (nutritional) |
|
E858.5 |
Accidental poisoning by water, mineral, and uric acid metabolism drugs |
|
E933.3 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, alkalizing agents |
|
E943.0 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antacids and antigastric secretion drugs |
|
E944.0-E944.5 |
Drugs, medicinal and biological substances causing adverse effects in therapeutic use, water, mineral, and uric acid metabolism drugs |
|
V45.89 |
Other postsurgical status (absorption by bone following parathyroidectomy) |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|